Doenças Infecciosas e Parasitarias

Immune responses and severe dengue: what have we learned?

Current opinion in infectious diseases. 2024 Oct; 37(Oct):349-356. doi: 10.1097/QCO.0000000000001040. pii: .

Current challenges in neurocysticercosis: recent data and where we are heading.

Current opinion in infectious diseases. 2024 Oct; 37(Oct):313-319. doi: 10.1097/QCO.0000000000001036. pii: .

Microbiology of catheter-associated bloodstream infection: differences according to catheter type.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2024 Nov; 148(Nov):107247. doi: 10.1016/j.ijid.2024.107247. pii: S1201-9712(24)00318-7.

Chikungunya vaccine VLA1553 induces sustained protective antibody concentrations.

The Lancet. Infectious diseases. 2024 Dec; 24(Dec):1298-1299. doi: 10.1016/S1473-3099(24)00432-8. pii: S1473-3099(24)00432-8.

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

JAMA. 2025 Feb; 333(Feb):609-628. doi: 10.1001/jama.2024.24543. pii: .

A Review of Antibacterial Candidates with New Modes of Action.

ACS infectious diseases. 2024 Oct; 10(Oct):3440-3474. doi: 10.1021/acsinfecdis.4c00218. pii: .

The challenges of PrEP.

The Lancet. Infectious diseases. 2025 Nov; 25(Nov):1176. doi: 10.1016/S1473-3099(25)00539-0. pii: S1473-3099(25)00539-0.

Vaccination Against Herpes Zoster in Adults: Current Strategies in European Union Countries.

Vaccines. 2025 Oct; 13(Oct):doi: 10.3390/vaccines13101073. pii: 1073.

Global Transmission, Prevention, Control, and Treatment of Mpox Virus in 2025: A Comprehensive Review from Infection Mechanisms to Vaccine Development.

Vaccines. 2025 Oct; 13(Oct):doi: 10.3390/vaccines13101071. pii: 1071.

Vaccine Development for Influenza Virus.

Vaccines. 2025 Oct; 13(Oct):doi: 10.3390/vaccines13101068. pii: 1068.

Effect of Influenza Vaccination on Mortality and Heart Failure Hospitalization in Heart Failure Patients.

Vaccines. 2025 Oct; 13(Oct):doi: 10.3390/vaccines13101055. pii: 1055.

Neurosyphilis.

Annals of neurology. 2025 Sep; doi: 10.1002/ana.78016. pii: .

Comment on: Use of teicoplanin monotherapy for the treatment of enterococcal infective endocarditis: a retrospective and comparative study at a referral centre.

The Journal of antimicrobial chemotherapy. 2025 May; doi: 10.1093/jac/dkaf138. pii: dkaf138.

Malaria.

The New England journal of medicine. 2025 Apr; 392(Apr):1320-1333. doi: 10.1056/NEJMra2405313. pii: .

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

JAMA. 2025 Feb; 333(Feb):609-628. doi: 10.1001/jama.2024.24543. pii: .

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis.

The New England journal of medicine. 2025 Jan; 392(Jan):468-482. doi: 10.1056/NEJMoa2400327. pii: .